This information was published on 2026-07-10T07:42 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2665805 (IR 1924665) |
| (220) |
30 Apr 2026
|
| (300) |
DE, 06 Nov 2025, 30 2025 011 391
|
| (511) (510) |
Class 42
Biological research, clinical research and medical research; scientific research; pharmaceutical research and development; preparation of reports relating to scientific research; research and development services in the field of antibodies; research and testing services in the fields of bacteriology and virology; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; conducting clinical trials for pharmaceutical products; consultancy relating to pharmaceutical research and development; preparation of scientific reports; conducting of scientific studies; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; advisory services relating to scientific research; pharmaceutical product evaluation; genetic testing for scientific research purposes; research and development services in the field of gene therapy; testing services in the field of antibodies; testing services for vaccines and medicines; research and development in the field of cell therapies; testing services for gene or cell therapies. |
| (540) | TRUVERNA |
| (550) | Word |
| (730) |
Merck KGaA
|
Find out more about publications on the About page.